LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Sells $95,040.00 in Stock

LifeStance Health Group, Inc. (NASDAQ:LFST) insider Ujjwal Ramtekkar sold 16,000 shares of LifeStance Health Group stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $5.94, for a total value of $95,040.00. Following the completion of the sale, the insider now directly owns 113,435 shares in the company, valued at $673,803.90. This represents a 12.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

LifeStance Health Group Trading Up 0.7%

NASDAQ LFST traded up $0.04 on Monday, reaching $5.88. 1,692,560 shares of the company were exchanged, compared to its average volume of 1,601,939. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. The business’s fifty day moving average price is $6.24 and its 200 day moving average price is $7.08. The stock has a market capitalization of $2.29 billion, a P/E ratio of -22.62 and a beta of 1.22. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $8.61.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Canaccord Genuity Group started coverage on LifeStance Health Group in a report on Thursday, April 3rd. They issued a “buy” rating and a $8.00 price objective on the stock. KeyCorp assumed coverage on shares of LifeStance Health Group in a research report on Tuesday, April 8th. They issued an “overweight” rating and a $9.00 target price for the company. UBS Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $8.50 price target on the stock in a research report on Tuesday, May 27th. Finally, William Blair reaffirmed an “outperform” rating on shares of LifeStance Health Group in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, LifeStance Health Group presently has a consensus rating of “Moderate Buy” and an average price target of $8.50.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of LFST. Vanguard Group Inc. grew its holdings in shares of LifeStance Health Group by 5.0% in the first quarter. Vanguard Group Inc. now owns 11,221,237 shares of the company’s stock valued at $74,733,000 after purchasing an additional 531,841 shares during the period. Jennison Associates LLC boosted its holdings in LifeStance Health Group by 2.1% in the 1st quarter. Jennison Associates LLC now owns 8,255,236 shares of the company’s stock valued at $54,980,000 after purchasing an additional 168,856 shares during the last quarter. Wellington Management Group LLP grew its stake in shares of LifeStance Health Group by 2.3% in the 1st quarter. Wellington Management Group LLP now owns 5,399,293 shares of the company’s stock valued at $35,959,000 after buying an additional 123,056 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of LifeStance Health Group by 87.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company’s stock valued at $25,977,000 after buying an additional 1,643,390 shares during the period. Finally, Geode Capital Management LLC increased its holdings in shares of LifeStance Health Group by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company’s stock worth $25,546,000 after buying an additional 13,293 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.